FK506 binding protein: Difference between revisions

(81 intermediate revisions by 3 users not shown)

Line 1:

~~{{STRUCTURE_1fkd| PDB~~=~~1fkd | SIZE~~=~~400| SCENE~~= ~~|right|CAPTION~~=~~Human FKBP12 complex with immunosuppressant~~, [[~~1fkd~~]] }}

== Function ==

''FK506 binding protein'' (FKBP) is a prolyl isomerase related to the cyclophilins. FKBP is a folding chaperone for proteins containing prolines. FKBP12 ~~binds~~ the ~~immunosuppressor tacrolimus (FK506) which~~ is ~~used against organ rejection~~.

'''FK506 binding protein (FKBP)''' is a prolyl isomerase related to the [[Cyclophilin|cyclophilins]]. FKBP is a folding chaperone for proteins containing prolines<ref>PMID:18635947</ref>.

*'''FKBP3''' is involved in immunoregulation and protein folding<ref>PMID:34281390</ref>.

*'''FKBP8''' inhibits accumulation of misfiled proteins in the heart<ref>PMID:29129702</ref>.

*'''FKBP12''' is a physiologic regulator of cell cycle<ref>PMID:11226255</ref>.

*'''FKBP12.6''' stabilises the Ryan-dine receptor, preventing aberrant channel activation<ref>PMID:12837242</ref>.

*'''FKBP13''' is an ER-resident molecular chaperone and has a role in inflammation and fibrosis protection<ref>PMID:33253593</ref>.

*'''FKBP22''' has peptidyl prolly cis-trans isomerase activity<ref>PMID:19558490</ref>.

*'''FKBP25''' has a role in the repair of DNA double-stranded breaks<ref>PMID:30620620</ref>.

*'''FKBP35''' is an essential malarial enzyme <ref>PMID:33209191</ref>.

*'''FKBP36''' has a role in spermatogenesis<ref>PMID:19001379</ref>.

*'''FKBP38''' is expressed in mitochondria and inhibits apoptosis by recruiting Bcl-2 and Bcl-xL<ref>PMID:24657651</ref>.

*'''FKBP39''' may act as a transcriptional modulator of 20-hydroxyecdysone and juvenile hormone transduction<ref>PMID:29337690</ref>.

*'''FKBP42''' has a role in morphogenesis and development of higher plants<ref>PMID:17045295</ref>.

*'''FKBP51''' is a biomarker of metabolic dysfunction<ref>PMID:34481731</ref>.

*'''FKBP52''' has a role in regulation of steroid receptor signaling<ref>PMID:15381148</ref>. See detains in [[Human FKBP52]].

*'''FKBP59''' or '''Hsp56''' has a role in maintaining steroid receptors in an inactive state<ref>PMID:7689858</ref>.

*'''FKBP73''' acts as a molecular chaperone<ref>PMID:12012248</ref>. See details in [[Wheat FKBP73]].

~~{{TOC limit|limit=2}}~~

For more details see

* [[Peptidyl-prolyl cis-trans isomerase]] for '''SlyD'''

== Relevance ==

'''FKBP12''' binds the immunosuppressor tacrolimus (ascomycin FK506) which is used against organ rejection and rapamycin<ref>PMID:9275110</ref>.

== Disease ==

Mutations in '''FKBP14''' cause Ehlers-Danlos syndrome<ref>PMID:22265013</ref>.

==Wheat FKBP73 and its comparison with human FKBP52<ref >PMID:20306145</ref>==

Ribbon representation of the <scene name='3jym/Cv/3'>three FKBP domains</scene>; wFK73_1 (residues 1–148) in blueviolet, wFK73_2 (residues 149–266) in cyan and wFK73_3 (residues 267–386) in magenta ([[3jym]]). The wFK73_1 domain exhibits electron density only between residues 33–38, 54–69 and 87–148. The bulges and the flaps as well as the N- and C-termini are labeled. The three FK506 binding (FK) domains of wFKBP73 are held together mainly by <scene name='3jym/Cv/4'>salt bridge networks</scene> situated between each pair of domains. The wFK73_2-wFK73_1 domains are held by a salt bridge between Lys162–Glu62, and a salt bridge network between Arg151–Asp61 and Glu58. The interface between wFK73_2-wFK73_3 is held by two salt bridges between Lys204–Glu269, and Glu178–Lys279. The interactions Lys162–Glu62 and Glu178–Lys279, involve conserved residues (Glu62 from wFK73_1 and Glu178 from wFK73_2, Lys162 from wFK73_2 and Lys279 from wFK73_3).

The 3D structures of several FKBP family members from various species are solved, most of them comprise 1-2 FK domains (''e.g.'' human FKBP52, known also as FKBP4), while wFKBP73 has 3 FK domains which is characteristic to plants. A sequence-based structure comparison between each of the 3 FK domains of wFKBP73 and the 2 FK domains of hFKBP52 ([[1q1c]]) was performed. All 3 FK domains of wFKBP73 adopt a typical FK fold exhibiting significant diversity when superimposed. They are arranged in a linear manner in space as observed in the 2 FK domains of hFKBP52. While the 2 FK domains of hFKBP52 are in the same orientation, the orientation between any 2 consecutive wFK73 domains is different than that between the two FK domains of hFKBP52. <scene name='3jym/Al/2'>Superposition</scene> of the wFK73_1 (in blueviolet) and wFK73_2 (in cyan) domains on hFK52_1 (in yellow) and hFK52_2 (in blue) revealed that while wFK73_2 is perfectly aligned with hFK52_2, N-terminal wFK73_1 does not align with hFK52_1 (yellow). Similarly, <scene name='3jym/Al/3'>superposition</scene> of the wFK73_2 and wFK73_3 (in magenta) domains on hFKBP52 revealed that while wFK73_2 is perfectly aligned with hFK52_1 (in yellow), wFK73_3 does not align with hFK52_2. This unique arrangement of wFKBP73 causes that the α-helices of <scene name='3jym/Al/4'>wFKBP73 3 FK domains</scene> are exposed on the same surface, while the <scene name='3jym/Al/5'>2 α-helices of hFK52</scene> are presented on opposite surfaces.

It was shown that 12 conserved residues (for wFK73_1 domain they are Tyr67, Phe77, Asp78, Arg83, Phe87, Gln95, Val96, Ile97, Trp100, Tyr123, Ile132, and Phe140) of the FK1 domains of hFKBP12, 13, 25, 51 and 52, are involved in binding the FK506 or rapamycin. Since only the FK1 domains contain all the conserved amino acids (in contrast to FK2 and/or FK3 domains), only they exhibit PPIase activity, which can be inhibited by the binding of the drugs FK506, and rapamycin. These conserved residues form the hydrophobic cavity. The structure of hFKBP12 ([[2ppn]]) demonstrates a good example of this <scene name='3jym/Cavity/1'>cavity</scene>. All these residues are conserved in the wFK73_1 domain, it could be assumed that a similar cavity is also formed in wFK73_1, although some of these residues are missing electron density in the wFK73 structure and, therefore, it can not be seen. Domain wFK73_3 has <scene name='3jym/Cavity/3'>narrower cavity</scene>, whereas wFK73_2 <scene name='3jym/Cavity/4'>lacks this cavity at all</scene>. Conserved residues are colored yellow. So, the lack of drug binding of the wFK73_2 and wFK73_3 domains could be explained by the absence of the conserved drug binding residues. This is in agreement with the fact that the FK2 domains of hFKBP51 and hFKBP52 and the single FK domains of FKBP38, DmFKBP45 and AtFKBP42, all lacking the conserved residues, do not exhibit drug binding.

==SlyD<ref >DOI 10.1007/s00775-011-0855-y</ref>==

SlyD belongs to the FK506-binding protein (FKBP) family with both peptidylprolyl isomerase (PPIase) and chaperone activities, and is considered to be a ubiquitous cytosolic protein-folding facilitator in bacteria. It possesses a histidine- and cysteine-rich C-terminus binding to selected divalent metal ions (''e.g.'', Ni2+, Zn2+), which is important for its involvement in the maturation processes of metalloenzymes. The solution structure of <scene name='Journal:JBIC:14/Cv/3'>C-terminus-truncated SlyD</scene> from ''Helicobacter pylori'' (HpSlyDΔC) was determined ([[2kr7]]). HpSlyDΔC folds into <scene name='Journal:JBIC:14/Cv/4'>two well-separated, orientation-independent domains:</scene> the PPIase-active FKBP domain (in cyan) and the chaperone-active insert-in-flap (IF) domain (in red), linkers are in darkmagenta. The FKBP domain consists of a four-stranded antiparallel <scene name='Journal:JBIC:14/Cv/5'>β-sheet with an α-helix on one side, whereas the IF domain folds into a four-stranded antiparallel β-sheet accompanied by a short α-helix.</scene> Intact ''H. pylori'' SlyD binds both Ni2+ and Zn2+, with dissociation constants of 2.74 and 3.79 μM respectively. Intriguingly, binding of Ni2+ instead of Zn2+ induces protein conformational changes around the <scene name='Journal:JBIC:14/Cv/6'>active sites of the FKBP domain, implicating a regulatory role of nickel</scene> (residues experiencing relatively large chemical shift perturbations upon interactions of HpSlyDΔC with Ni2+ are in blueviolet). <scene name='Journal:JBIC:14/Cv/7'>The twin-arginine translocation (Tat) signal peptide from the small subunit of [NiFe] hydrogenase (HydA) binds the protein at the IF domain</scene> (residues in orange). Surprisingly, several residues (Ile41, Gly42, Ile46, and Asn31) were from the FKBP domain, which is likely due to the binding of the longer n-region of HydA Tat peptide to the FKBP domain. Nickel binding and the recognition of the Tat signal peptide by the protein suggest that SlyD participates in [NiFe] hydrogenase maturation processes.

== 3D Structures of FKBP ==

[[FKBP 3D structures]]

</StructureSection>

== References ==

[[Category:Topic Page]]

[[Category: Topic Page]]

FK506 binding protein: Difference between revisions

Navigation menu

Page actions

Page actions

Personal tools

Navigation

Search

Tools

@@ Line 1: / Line 1: @@
-{{STRUCTURE_1fkd|  PDB=1fkd  | SIZE=400| SCENE= |right|CAPTION=Human FKBP12 complex with immunosuppressant, [[1fkd]] }}
+<StructureSection load='' size='350' scene='3jym/Cv/2' caption='Wheat FKBP506 domains.  Domain 1 (purple), 2  (cyan), 3 (magenta). [[3jym]]'>
+== Function ==
-''FK506 binding protein'' (FKBP) is a prolyl isomerase related to the cyclophilins.  FKBP is a folding chaperone for proteins containing prolines.  FKBP12 binds the immunosuppressor tacrolimus (FK506) which is used against organ rejection.
+'''FK506 binding protein (FKBP)''' is a prolyl isomerase related to the [[Cyclophilin|cyclophilins]].  FKBP is a folding chaperone for proteins containing prolines<ref>PMID:18635947</ref>.
+*'''FKBP3''' is involved in immunoregulation and protein folding<ref>PMID:34281390</ref>.
+*'''FKBP8''' inhibits accumulation of misfiled proteins in the heart<ref>PMID:29129702</ref>.
+*'''FKBP12''' is a physiologic regulator of cell cycle<ref>PMID:11226255</ref>.
+*'''FKBP12.6''' stabilises the Ryan-dine receptor, preventing aberrant channel activation<ref>PMID:12837242</ref>.
+*'''FKBP13''' is an ER-resident molecular chaperone and has a role in inflammation and fibrosis protection<ref>PMID:33253593</ref>.
+*'''FKBP22''' has peptidyl prolly cis-trans isomerase activity<ref>PMID:19558490</ref>.
+*'''FKBP25''' has a role in the repair of DNA double-stranded breaks<ref>PMID:30620620</ref>.
+*'''FKBP35''' is an essential malarial enzyme <ref>PMID:33209191</ref>.
+*'''FKBP36''' has a role in spermatogenesis<ref>PMID:19001379</ref>.
+*'''FKBP38''' is expressed in mitochondria and inhibits apoptosis by recruiting Bcl-2 and Bcl-xL<ref>PMID:24657651</ref>.
+*'''FKBP39''' may act as a transcriptional modulator of 20-hydroxyecdysone and juvenile hormone transduction<ref>PMID:29337690</ref>.
+*'''FKBP42''' has a role in morphogenesis and development of higher plants<ref>PMID:17045295</ref>.
+*'''FKBP51''' is a biomarker of metabolic dysfunction<ref>PMID:34481731</ref>.
+*'''FKBP52''' has a role in regulation of steroid receptor signaling<ref>PMID:15381148</ref>.  See detains in [[Human FKBP52]].
+*'''FKBP59''' or '''Hsp56''' has a role in maintaining steroid receptors in an inactive state<ref>PMID:7689858</ref>.
+*'''FKBP73''' acts as a molecular chaperone<ref>PMID:12012248</ref>.  See details in [[Wheat FKBP73]].
-  {{TOC limit|limit=2}}
+For more details see<br />
+* [[Peptidyl-prolyl cis-trans isomerase]] for '''SlyD'''<br />
+== Relevance ==
+'''FKBP12''' binds the immunosuppressor tacrolimus (ascomycin FK506) which is used against organ rejection and rapamycin<ref>PMID:9275110</ref>.
+== Disease ==
+Mutations in '''FKBP14''' cause Ehlers-Danlos syndrome<ref>PMID:22265013</ref>.
+==Wheat FKBP73 and its comparison with human FKBP52<ref >PMID:20306145</ref>==
+Ribbon representation of the <scene name='3jym/Cv/3'>three FKBP domains</scene>; <font color='blueviolet'><b>wFK73_1 (residues 1–148) in blueviolet</b></font>, <span style="color:cyan;background-color:black;font-weight:bold;">wFK73_2 (residues 149–266) in cyan</span> and <font color='magenta'><b>wFK73_3 (residues 267–386) in magenta</b></font> ([[3jym]]). The wFK73_1 domain exhibits electron density only between residues 33–38, 54–69 and 87–148. The bulges and the flaps as well as the N- and C-termini are labeled. The three FK506 binding (FK) domains of wFKBP73 are held together mainly by <scene name='3jym/Cv/4'>salt bridge networks</scene> situated between each pair of domains. The wFK73_2-wFK73_1 domains are held by a salt bridge between Lys162–Glu62, and a salt bridge network between Arg151–Asp61 and Glu58. The interface between wFK73_2-wFK73_3 is held by two salt bridges between Lys204–Glu269, and Glu178–Lys279. The interactions Lys162–Glu62 and Glu178–Lys279, involve conserved residues (Glu62 from wFK73_1 and Glu178 from wFK73_2, Lys162 from wFK73_2 and Lys279 from wFK73_3).
+{{Clear}}
+The 3D structures of several FKBP family members from various species are solved, most of them comprise 1-2 FK domains (''e.g.'' human FKBP52, known also as FKBP4), while wFKBP73 has 3 FK domains which is characteristic to plants. A sequence-based structure comparison between each of the 3 FK domains of wFKBP73 and the 2 FK domains of hFKBP52 ([[1q1c]]) was performed. All 3 FK domains of wFKBP73 adopt a typical FK fold exhibiting significant diversity when superimposed. They are arranged in a linear manner in space as observed in the 2 FK domains of hFKBP52. While the 2 FK domains of hFKBP52 are in the same orientation, the orientation between any 2 consecutive wFK73 domains is different than that between the two FK domains of hFKBP52. <scene name='3jym/Al/2'>Superposition</scene> of the <font color='blueviolet'><b>wFK73_1 (in blueviolet)</b></font> and <span style="color:cyan;background-color:black;font-weight:bold;">wFK73_2 (in cyan)</span> domains on hFK52_1 (in yellow) and <font color='blue'><b>hFK52_2 (in blue)</b></font> revealed that while <span style="color:cyan;background-color:black;font-weight:bold;">wFK73_2</span> is perfectly aligned with <font color='blue'><b>hFK52_2</b></font>, N-terminal <font color='blueviolet'><b>wFK73_1</b></font> does not align with hFK52_1 (yellow). Similarly, <scene name='3jym/Al/3'>superposition</scene> of the <span style="color:cyan;background-color:black;font-weight:bold;">wFK73_2</span> and <font color='magenta'><b>wFK73_3 (in magenta)</b></font> domains on hFKBP52 revealed that while <span style="color:cyan;background-color:black;font-weight:bold;">wFK73_2</span> is perfectly aligned with hFK52_1 (in yellow), <font color='magenta'><b>wFK73_3</b></font> does not align with <font color='blue'><b>hFK52_2</b></font>. This unique arrangement of wFKBP73 causes that the α-helices of <scene name='3jym/Al/4'>wFKBP73 3 FK domains</scene> are exposed on the same surface, while the <scene name='3jym/Al/5'>2 α-helices of hFK52</scene> are presented on opposite surfaces.
+{{Clear}}
+It was shown that 12 conserved residues (for wFK73_1 domain they are Tyr67, Phe77, Asp78, Arg83, Phe87, Gln95, Val96, Ile97, Trp100, Tyr123, Ile132, and Phe140) of the FK1 domains of hFKBP12, 13, 25, 51 and 52, are involved in binding the FK506 or rapamycin. Since only the FK1 domains contain all the conserved amino acids (in contrast to FK2 and/or FK3 domains), only they exhibit PPIase activity, which can be inhibited by the binding of the drugs FK506, and rapamycin. These conserved residues form the hydrophobic cavity. The structure of hFKBP12 ([[2ppn]]) demonstrates a good example of this <scene name='3jym/Cavity/1'>cavity</scene>. All these residues are conserved in the wFK73_1 domain, it could be assumed that a similar cavity is also formed in wFK73_1, although some of these residues are missing electron density in the wFK73 structure and, therefore, it can not be seen. Domain <font color='magenta'><b>wFK73_3</b></font> has <scene name='3jym/Cavity/3'>narrower cavity</scene>, whereas <span style="color:cyan;background-color:black;font-weight:bold;">wFK73_2</span> <scene name='3jym/Cavity/4'>lacks this cavity at all</scene>. Conserved residues are colored yellow. So, the lack of drug binding of the wFK73_2 and wFK73_3 domains could be explained by the absence of the conserved drug binding residues. This is in agreement with the fact that the FK2 domains of hFKBP51 and hFKBP52 and the single FK domains of FKBP38, DmFKBP45 and AtFKBP42, all lacking the conserved residues, do not exhibit drug binding.
+==SlyD<ref >DOI 10.1007/s00775-011-0855-y</ref>==
+SlyD belongs to the FK506-binding protein (FKBP) family with both peptidylprolyl isomerase (PPIase) and chaperone activities, and is considered to be a ubiquitous cytosolic protein-folding facilitator in bacteria. It possesses a histidine- and cysteine-rich C-terminus binding to selected divalent metal ions (''e.g.'', Ni<sup>2+</sup>, Zn<sup>2+</sup>), which is important for its involvement in the maturation processes of metalloenzymes. The solution structure of <scene name='Journal:JBIC:14/Cv/3'>C-terminus-truncated SlyD</scene> from ''Helicobacter pylori'' (HpSlyDΔC) was determined ([[2kr7]]). HpSlyDΔC folds into <scene name='Journal:JBIC:14/Cv/4'>two well-separated, orientation-independent domains:</scene> the <span style="color:cyan;background-color:black;font-weight:bold;">PPIase-active FKBP domain (in cyan)</span> and the <font color='red'><b>chaperone-active insert-in-flap (IF) domain (in red)</b></font>, <font color='darkmagenta'><b>linkers are in darkmagenta</b></font>. The FKBP domain consists of a four-stranded antiparallel <scene name='Journal:JBIC:14/Cv/5'>β-sheet with an α-helix on one side, whereas the IF domain folds into a four-stranded antiparallel β-sheet accompanied by a short α-helix.</scene> Intact ''H. pylori'' SlyD binds both Ni<sup>2+</sup> and Zn<sup>2+</sup>, with dissociation constants of 2.74 and 3.79 μM respectively. Intriguingly, binding of Ni<sup>2+</sup> instead of Zn<sup>2+</sup> induces protein conformational changes around the <scene name='Journal:JBIC:14/Cv/6'>active sites of the FKBP domain, implicating a regulatory role of nickel</scene> <font color='blueviolet'><b>(residues experiencing relatively large chemical shift perturbations upon interactions of HpSlyDΔC with Ni<sup>2+</sup> are in blueviolet)</b></font>. <scene name='Journal:JBIC:14/Cv/7'>The twin-arginine translocation (Tat) signal peptide from the small subunit of [NiFe] hydrogenase (HydA) binds the protein at the IF domain</scene> <font color='orange'><b>(residues in orange)</b></font>. Surprisingly, several residues (Ile41, Gly42, Ile46, and Asn31) were from the FKBP domain, which is likely due to the binding of the longer n-region of HydA Tat peptide to the FKBP domain. Nickel binding and the recognition of the Tat signal peptide by the protein suggest that SlyD participates in [NiFe] hydrogenase maturation processes.
 == 3D Structures of FKBP ==
+[[FKBP 3D structures]]
+</StructureSection>
+== References ==
+<references/>
-[[Category:Topic Page]]
+[[Category: Topic Page]]